Screening out the anti-insomnia components from Prunella vulgaris L. based on plasma pharmacochemistry combined with pharmacodynamic experiments and UPLC-MS/MS analysis
Tian-Feng Lin,Jun-Na Qiu,Shuang Zhang,Yan Zhang,Yu Zhang,Meng Sun,Jin-Hua Zhang,Bin Liu,Fa-Feng Cheng,Yan-Yan Jiang,Tian-feng Lin,Jun-na Qiu,Jin-hua Zhang,Fa-feng Cheng,Yan-yan Jiang
DOI: https://doi.org/10.1016/j.jep.2021.114373
IF: 5.195
2021-10-01
Journal of Ethnopharmacology
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Ethnopharmacological relevance</h3><p><em>Prunella vulgaris</em> L. (<em>P. vulgaris</em>) is a medicinal plant belonging to the Labiatae family, and its dried spikes is called as Xiakucao in China, which is a common traditional Chinese medicine with the activities of clearing the liver and expelling fire, improving eyesight, dispersing nodules and detumescence. Modern pharmacological studies have proved that <em>P. vulgaris</em> has various pharmacological activities such as immunomodulatory, antiviral, antibacterial and anti-insomnia activities.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aims of this review</h3><p><em>P. vulgaris</em> have been reported to have anti-insomnia effects. Nevertheless, the pharmacodynamic substance basis of this anti-insomnia effect is still unclear. The aim of this study was to identify the active components responsible for evoking the anti-insomnia effect of <em>P. vulgaris</em> and to evaluate its anti-insomnia effect.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials and methods</h3><p>In this study, we proposed a method combined with pharmacodynamic experiments, extraction and enrichment of chemical components, and the plasma pharmacochemistry to screen out the anti-insomnia components of <em>P. vulgaris</em>. Firstly, the active eluted fraction of the ethanol extract was screened out based on pharmacodynamic tracing method, and then the chemical composition was analyzed systematically by UPLC-MS/MS. Thirdly, pharmacodynamic tracing method and silica gel column chromatography were employed to screen out the active fraction of 70% ethanol eluted fraction, and its bioactive components in vitro and in vivo were identified by UPLC-MS/MS. Finally, screening out the anti-insomnia components of <em>P. vulg</em>aris by comparing the difference between in vivo and in vitro components, and three potentially bioactive ingredients were validated experimentally.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>It was confirmed that the fraction eluted with 70% ethanol from macroporous adsorption resin column was responsible for the anti-insomnia efficacy, and 55 compounds were identified or preliminarily identified. Then totally 9 compounds in vitro and 12 compounds in vivo from the active fraction of 70% ethanol eluted fraction were tentatively identified. Among them, mangiferin, rosmarinic acid and salviaflaside were the prototype components of <em>P. vulgaris</em>, which indicated that the three compounds might play the key role in the anti-insomnia activities. In vivo, compared to blank control group, the three compounds significantly shortened the sleeping latency and prolonged the sleeping time produced by pentobarbital sodium.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>This study clarified that mangiferin, rosmarinic acid and salviaflaside were considered as the anti-insomnia components of <em>P. vulgaris</em>. This is the first study on screening out the active ingredients responsible for evoking the anti-insomnia effect of <em>P. vulgaris</em>. The three compounds of <em>P. vulgaris</em> may help develop one or more drugs to prevent or treat insomnia. Further investigations are recommended to define the mechanism of the anti-insomnia activity of <em>P. vulgaris</em>.</p>
pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences